HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
33.95 USD
-0.36 (-1.05%)
Taking everything into account, HIMS scores 5 out of 10 in our fundamental rating. HIMS was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HIMS get a neutral evaluation. Nothing too spectacular is happening here. HIMS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
HIMS had a positive operating cash flow in the past year.
HIMS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
HIMS has a better Return On Assets (5.99%) than 82.18% of its industry peers.
HIMS's Return On Equity of 23.03% is amongst the best of the industry. HIMS outperforms 90.10% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.84%, HIMS is in the better half of the industry, outperforming 60.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a better Profit Margin (6.05%) than 81.19% of its industry peers.
With a decent Operating Margin value of 5.96%, HIMS is doing good in the industry, outperforming 65.35% of the companies in the same industry.
HIMS has a Gross Margin of 75.01%. This is amongst the best in the industry. HIMS outperforms 90.10% of its industry peers.
In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
HIMS has more shares outstanding than it did 1 year ago.
HIMS has more shares outstanding than it did 5 years ago.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
HIMS has an Altman-Z score of 4.15. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
HIMS has a better Altman-Z score (4.15) than 76.24% of its industry peers.
The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
HIMS has a Debt to FCF ratio of 8.13. This is comparable to the rest of the industry: HIMS outperforms 53.47% of its industry peers.
A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
With a Debt to Equity ratio value of 1.67, HIMS is not doing good in the industry: 71.29% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 4.15 |
ROIC/WACC0.65
WACC8.96%
2.3 Liquidity
A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.88, HIMS is doing good in the industry, outperforming 75.25% of the companies in the same industry.
HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.64, HIMS is in the better half of the industry, outperforming 65.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.73%, which is quite impressive.
Measured over the past years, HIMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.35% on average per year.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.02%.
The Revenue has been growing by 75.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.75% yearly.
Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 21.08% on average per year.
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y41.75%
Revenue Next Year60.27%
Revenue Next 2Y37.63%
Revenue Next 3Y31.12%
Revenue Next 5Y21.08%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 62.87, which means the current valuation is very expensive for HIMS.
The rest of the industry has a similar Price/Earnings ratio as HIMS.
The average S&P500 Price/Earnings ratio is at 26.92. HIMS is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 56.65 indicates a quite expensive valuation of HIMS.
HIMS's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of HIMS to the average of the S&P500 Index (23.46), we can say HIMS is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.87 | ||
| Fwd PE | 56.65 |
4.2 Price Multiples
HIMS's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 64.68 | ||
| EV/EBITDA | 45.15 |
4.3 Compensation for Growth
HIMS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 13.84% in the coming years.
PEG (NY)N/A
PEG (5Y)1.04
EPS Next 2Y5.34%
EPS Next 3Y13.84%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:HIMS (12/29/2025, 2:46:07 PM)
33.95
-0.36 (-1.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners94.02%
Inst Owner Change15.86%
Ins Owners5.88%
Ins Owner Change-3.41%
Market Cap7.73B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target46.4 (36.67%)
Short Float %32.86%
Short Ratio2.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-5.57%
PT rev (3m)-9.7%
EPS NQ rev (1m)-65.22%
EPS NQ rev (3m)-81.79%
EPS NY rev (1m)-21.88%
EPS NY rev (3m)-23.52%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.96%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.87 | ||
| Fwd PE | 56.65 | ||
| P/S | 3.5 | ||
| P/FCF | 64.68 | ||
| P/OCF | 23.77 | ||
| P/B | 13.3 | ||
| P/tB | 60.94 | ||
| EV/EBITDA | 45.15 |
EPS(TTM)0.54
EY1.59%
EPS(NY)0.6
Fwd EY1.77%
FCF(TTM)0.52
FCFY1.55%
OCF(TTM)1.43
OCFY4.21%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)1.04
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 4.15 |
F-Score3
WACC8.96%
ROIC/WACC0.65
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y41.75%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.27%
Revenue Next 2Y37.63%
Revenue Next 3Y31.12%
Revenue Next 5Y21.08%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year351.26%
EBIT Next 3Y90.18%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to decline by -12.6% in the next year.